News

Pure Global and MEDIcept Partner to Drive Medtech Growth, Innovation

The two companies are enhancing their ability to navigate regulatory landscapes and effectively facilitate market access.

Published on:
June 10, 2024

Pure Global is teaming up with MEDIcept to unlock new opportunities and streamline market access in the medical device and in-vitro diagnostics (IVD) industries.

The two companies aim to leverage their expertise and networks to efficiently navigate regulatory complexities. Pure Global claims it has extensive experience in global representation and registration services as well as cutting-edge AIGC regulatory tools; MEDIcept, meanwhile, boasts a solid reputation in regulatory, quality, and clinical services for the U.S. and EU markets. Together, they provide comprehensive solutions ranging from regulatory affairs and quality assurance to clinical support and market representation across various regions—the United States, Latin America, Europe, the Middle East, and Asia Pacific, the firms contend.


“Pure Global’s strategic alliance with MEDIcept will help accelerate medtech innovation and streamline compliance. By combining their hundreds of successful submissions with our AI-powered and data driven regulatory solutions, we empower clients worldwide to bring life-changing medtech to market faster, with reduced costs and higher regulatory success,” Pure Global CEO Zhu (Phyllis) Meng said.

The alliance unites two companies with complementary strengths, enhancing their ability to navigate regulatory landscapes and facilitate market access effectively, executives said. By pooling their expertise, Pure Global and MEDIcept aim to drive growth and innovation, ultimately benefiting clients and the industry.

Pure Global and MEDIcept are aligned in their pursuit of several objectives through this collaboration:

  • Enhancing capabilities by leveraging respective networks and expertise
  • Expanding service offerings into additional regions, including the United States, Europe, the Middle East, Latin America, and Asia-Pacific
  • Leveraging each other’s strengths to bolster capacity and expertise
  • Designing pre- and post-market global clinical studies for comprehensive support
  • Empowering research efficiency through Pure Global’s AIGC tools

Both Pure Global and MEDIcept will continue their operations with an expanded service portfolio. The initial action following the alliance will involve a collaborative marketing effort to promote each other’s services. By working together, Pure Global and MEDIcept aim to advance the medical device industry and remove barriers to innovation. “With this strategic alliance we are strengthening our worldwide presence and can serve the needs of our customers anywhere. With teams of seasoned consultants both MEDIcept and Pure Global offer deep expertise across a wide range of compliance needs. Together, this relationship will efficiently help international companies with FDA and US quality, regulatory, clinical, and reimbursement concerns and rapidly provide tailored, trusted solutions to meet their unique challenges,” MEDIcept President David Rothkopf stated. Established in 2020, Pure Global considers itself a global growth partner to medtech companies, delivering smart, efficient market access solutions powered by transformative data and technology. The company has served more than 300 clients globally and has over 1,900 global registration certificates.MEDIcept has provided regulatory, quality, and clinical services for medical device and IVD manufacturers worldwide since its 1996 inception. The company is credited with more than 600 submissions, 1,000 audits, 50 clinical trials, and a successful track record of remediation activities.

Subscribe to newsletter
Subscribe to receive the latest blog posts to your inbox every week.
By subscribing, you agree to our Terms and Conditions.
Thank you for subscribing!
Oops! Something went wrong while submitting the form.
Read more

Latest News

Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.

Regulatory Update
November 13, 2024

This week, we bring you medical device regulatory update coverage from around the world, including new registration Q&A resources in Taiwan and Japan, UK relaunches ILAP pathway, Mexico will apply a new acquisition model, and more.

Regulatory Update
November 6, 2024

This week in medical device regulatory news, EU parliament moves toward a revision of the EU MDR, the UK enhances post-market surveillance requirements, US FDA prioritizes guidance revisions for 2025, and more.

Regulatory Update
October 30, 2024

Peru joins IMDRF, updated clinical trial guidance in Denmark, Romania implements new compliance requirements for professionals users, and more in this week's medical device regulatory update.

A necessary evil of a medical device company’s post-market responsibilities.

Contact us
Request information

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Our closest representative will get back to you within 24 hours.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Latest Blog Content

Explore our collection of articles, success stories, and regulatory updates, designed to help you take your product global.

Blog Article
EU Parliament Revises MDR and IVDR

On October 23, the European Parliament adopted a resolution revising specific elements of the Medical Devices Regulation (MDR) and the In Vitro Diagnostic Devices Regulation (IVDR). This resolution intends to address ongoing challenges in implementing the regulations by 2025 and to improve patient access to important medical products.

Blog Article
Language Challenges in MedTech Going Global and Our Solution

Multilingual documentation presents ongoing compliance and logistical hurdles for MedTech manufacturers. Transla.Ai is an industry-specific translation tool that can accelerate and streamline the translation process.

Medical device supply chain
Blog Article
Managing your medical device supply chain

The connection between supplier controls and business risks is becoming increasingly evident. In this article, we discuss perspectives on how to maintain a compliant medical device supply chain.

Blog Article
Brazil: Adapting to Evolving Regulatory Markets

Brazil aligns medical device regulations with global standards, including Europe and the US. Recent updates and international compatibility attract manufacturers.